Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN114591302B reveals a novel synthesis for high-purity antiviral intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Discover a novel persulfide reagent for asymmetric persulfides synthesis. Enhances purity, reduces toxicity, and offers scalable solutions for pharmaceutical intermediates.
Patent CN108300744B reveals enzymatic synthesis for high-purity D-heterocyclic amino acids. Discover cost-effective supply chain solutions and scalable manufacturing.
Patent CN113979937B details a PTCDA/g-C3N4 photocatalytic method for quinoline functionalization, offering cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Patent CN105198827A details high-yield Peramivir intermediate synthesis. Offers cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Advanced synthesis of Cefditoren Pivoxil Dimer ensuring high purity. Reliable supply chain partner for pharmaceutical intermediates and impurity standards.
Patent CN103224963A reveals a marine strain method for high-purity chiral amines. Discover cost reduction in pharmaceutical intermediates manufacturing and scalable biocatalysis.
Novel 5-step route for Ozanimod intermediates reduces cost and improves safety. Ideal for API intermediates manufacturing and supply chain optimization.
Novel Grignard-based synthesis offers scalable production. Reduces heavy metal reliance and simplifies purification for reliable supply chain integration.
Patent CN101203614A reveals a novel EDTA-complexed enzymatic resolution for high-purity S-escitalopram, offering scalable cost reduction in API manufacturing.
Novel process using chloroacetyl chloride reduces costs and improves stability for cefathiamidine production. Ideal for API manufacturers seeking efficient supply chains.
Novel two-step synthesis of lithocholic acid from hyodesoxycholic acid offers high yield and scalable production for pharmaceutical intermediate supply chains globally.
Novel macroporous resin purification enhances cefazolin acid purity and yield while reducing solvent usage for scalable pharmaceutical intermediate manufacturing.
Novel patent CN103012240B enables scalable atorvastatin calcium production with improved safety and cost efficiency for global pharmaceutical supply chains.
Advanced HCl-based recrystallization method ensures >99.5% purity and >90% yield, offering a reliable supply chain solution for oncology drug manufacturers.
Advanced one-pot catalytic synthesis for high-purity pharmaceutical intermediates. Reduces waste and cost for Vonoprazan production supply chains.
Patent CN107011354B reveals a high-purity AgNO3/SOCl2 nitration route for 5-ISMN, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1942476A details enzymatic acylation of rapamycin. Offers high yield, mild conditions, and eliminates heavy metal catalysts for pharmaceutical intermediates.
Advanced synthesis of Beraprost Sodium intermediates via patent CN110452100A. Offers safer conditions, higher yields, and reliable supply chain solutions.
Patent CN1028361C details asymmetric synthesis of 2(S)-glutaric acid intermediates, offering high purity and scalable routes for cardiovascular drug manufacturing.